1魏亚明 欧英贤 路继红 等.The apoptosis of HL-60,K562 and NB4 cells induced by arsenic trioxide [J].Medical Journal of National Defending Forces in Northwest China(西北国防医学杂志),. 被引量：1
2Cheson BD, Bennett JM, Kantariian H, et al. Report of an International Working Group to standardize response criteria for myelodysplastie syndromes. Blood, 2000,96(12),3671-367. 被引量：1
3Garzon R, Ellison R, Kirkhart B, et al. Updated safety experience with Trisenox (arsenic trioxide) injection. Presented as the 8th Congress of the European hematology Association, 12-15 June,2003, Lyon,France. 被引量：1
4List A, Beran M, Dipersio J,et al, Opportunities for Trisenox(arsenic trioxide) in the treatment of myelodysplastic syndromes.Leukemia, 2003,17(8) : 1499-1507. 被引量：1
5Vey N, Drefus F, Guerci A, et al. Trisenox (arsenic trioxide) in patients (pts) with myelodysplastic Syndromes (MDS) : preliminary results of a phase 1/2study. Presented as a poster at the 7th international Symposium on Myelodysplastie Syndromes, Paris,France, May 15-18,2003. 被引量：1
6Strupp C, Germing U, Aivado M, et al. Thalidomide for the treatment of patients with myelodysplastic syndrome. Leukemia,2002,16(1):1-6. 被引量：1
7Zorat F, Sherry V, Dutt D,et al. The clinical and biological effects of thalidomide in patients with myelodysplastic syndrome. Br J Haematol, 2001, 115(4) :881-894. 被引量：1
8Raza A, Meyer P, Dutt D, et al, Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes, Blood, 2001, 98 (4):958-965. 被引量：1
9List A, Beton M, Dipersio J, et al. Opportunities for Trisenox(arsenic trioxide)in the treatment of myelodysplasfic syndromes [J].Leukemia,2003,17(8): 1499 - 1507. 被引量：1
10Geissler K, Hinterberger W, Bettelheim P. Colony growth characteristic in chronic myelomonocytic leukemia [J]. Leuk Res, 1998,12:371-373. 被引量：1
2Cheson BD,Bennett JM,Kantaian H,et al. Report of an internationalworking group to standardize response criteria for myelodysplasticsyndromes[ J] . Bloods,2000, 96(12) :3671-3674. 被引量：1
3Ulrieh G,Nothert G,Corinna S,et al. Validation of the WHO PtoPos-al for anewel assiiications of Primarymyelodys Plastiesdromes : aretrosPeetiveanalysis of 1600 patients [ J ]. LeukaRes, 2000, 25 ( 12 ):983-993. 被引量：1
